Roivant Sciences is a global biopharmaceutical company focusedon reducing the time and cost of the drug development process to improve the lives of patients and their families. Roivant partners with innovativebiopharmaceutical companies and academic institutions to ensure that important medicines are rapidly delivered to patients.

The Roivant family of companies includes Myovant (focused on women’s health and prostate cancer), Axovant (neurology), Urovant (urology), Enzyvant (rare diseases), Dermavant (dermatology), Genevant (RNA therapeutics), Metavant (cardiometabolic diseases), Datavant (healthcare data analytics), and Arbutus (hepatitis B). There are 23 investigational drugs in 11 therapeutic areas being tested in over 50 clinical trials and over 300 nonclinical studies across our family of companies.

If you're interested in learning more about full time positions, come to our info session on 9/26 at 6:00 - 7:00pmin room 1690 in the Bob and Betty Beyster Building on North Campus.